Andrew J. Rowan

13.8k total citations
12 papers, 1.0k citations indexed

About

Andrew J. Rowan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew J. Rowan has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew J. Rowan's work include Cancer Genomics and Diagnostics (6 papers), Renal cell carcinoma treatment (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Andrew J. Rowan is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Renal cell carcinoma treatment (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Andrew J. Rowan collaborates with scholars based in United Kingdom, Denmark and United States. Andrew J. Rowan's co-authors include Charles Swanton, Zoltán Szállási, David Endesfelder, Nicolai J. Birkbak, Tejal Joshi, Maik Kschischo, Julian Downward, Alvin Lee, Nicholas McGranahan and P. Andrew Futreal and has published in prestigious journals such as Cancer Research, International Journal of Cancer and European Urology.

In The Last Decade

Andrew J. Rowan

12 papers receiving 1.0k citations

Peers

Andrew J. Rowan
Sara Akhavanfard United States
Alexander Penson United States
Nathalie Conte United Kingdom
Sara Widaa United Kingdom
Joshua D. Cohen United States
Mariam Jamal‐Hanjani United Kingdom
Laura M. Sack United States
Sara Akhavanfard United States
Andrew J. Rowan
Citations per year, relative to Andrew J. Rowan Andrew J. Rowan (= 1×) peers Sara Akhavanfard

Countries citing papers authored by Andrew J. Rowan

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Rowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Rowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Rowan more than expected).

Fields of papers citing papers by Andrew J. Rowan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Rowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Rowan. The network helps show where Andrew J. Rowan may publish in the future.

Co-authorship network of co-authors of Andrew J. Rowan

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Rowan. A scholar is included among the top collaborators of Andrew J. Rowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Rowan. Andrew J. Rowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hynds, Robert E., Assma Ben Aïssa, Kate H.C. Gowers, et al.. (2018). Expansion of airway basal epithelial cells from primary human non‐small cell lung cancer tumors. International Journal of Cancer. 143(1). 160–166. 18 indexed citations
2.
McGranahan, Nicholas, Rachel Rosenthal, Crispin T. Hiley, et al.. (2018). Abstract LB-A03: Allele specific HLA loss and immune escape in lung cancer evolution. Molecular Cancer Therapeutics. 17(1_Supplement). LB–A03. 1 indexed citations
3.
Soultati, Aspasia, Ben Challacombe, David Nicol, et al.. (2016). 217 Identifying the metastatic subclone by exhaustive sampling of primary and metastasis in clear cell renal cell carcinoma (ccRCC) pair. European Urology Supplements. 15(3). e217–e217. 2 indexed citations
4.
Dewhurst, Sally M., Nicholas McGranahan, Rebecca A. Burrell, et al.. (2014). Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution. Cancer Discovery. 4(2). 175–185. 287 indexed citations
5.
Gulati, Sakshi, Pierre Martinez, Tejal Joshi, et al.. (2014). Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers. European Urology. 66(5). 936–948. 126 indexed citations
6.
Gerlinger, Marco, James Larkin, Andrew J. Rowan, et al.. (2013). Abstract 4603: Intratumor heterogeneity in clear cell renal cell carcinoma (ccRCC): Multi-region sequencing redefines the mutational landscape of ccRCCs.. Cancer Research. 73(8_Supplement). 4603–4603. 1 indexed citations
7.
Martinez, Pierre, Nicolai J. Birkbak, Marco Gerlinger, et al.. (2013). Parallel evolution of tumour subclones mimics diversity between tumours. The Journal of Pathology. 230(4). 356–364. 63 indexed citations
8.
Gerlinger, Marco, Sergio A. Quezada, Karl S. Peggs, et al.. (2013). Ultra‐deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas. The Journal of Pathology. 231(4). 424–432. 74 indexed citations
9.
Lee, Alvin, David Endesfelder, Andrew J. Rowan, et al.. (2011). Chromosomal Instability Confers Intrinsic Multidrug Resistance. Cancer Research. 71(5). 1858–1870. 358 indexed citations
10.
Lee, Alvin, Rebecca Roylance, Jil Sander, et al.. (2011). CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid‐specific cancer cell death through autophagy induction. The Journal of Pathology. 226(3). 482–494. 52 indexed citations
11.
Kim, Jin Cheon, et al.. (1999). Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma. Diseases of the Colon & Rectum. 42(5). 640–648. 27 indexed citations
12.
Rowan, Andrew J., et al.. (1968). Myelopathy in Systemic Lupus Erythematosus. Archives of Neurology. 18(4). 337–349. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026